Hyeok Shim
About
Hyeok Shim is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology.
According to data from OpenAlex, Hyeok Shim has authored 37 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 10 papers in Pathology and Forensic Medicine and 7 papers in Molecular Biology. Recurrent topics in Hyeok Shim's work include Lymphoma Diagnosis and Treatment (8 papers), CNS Lymphoma Diagnosis and Treatment (6 papers) and Multiple Myeloma Research and Treatments (4 papers). Hyeok Shim is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), CNS Lymphoma Diagnosis and Treatment (6 papers) and Multiple Myeloma Research and Treatments (4 papers). Hyeok Shim collaborates with scholars based in South Korea, United States and Japan. Hyeok Shim's co-authors include Jae‐Yong Kwak, Na‐Ri Lee, Ho Sung Park, Su‐Bin Lee, Hong‐Seob So, Gi‐Su Oh, Ki‐Eun Hwang, Eun‐Taik Jeong, Keum Ha Choi and Hak-Ryul Kim and has published in prestigious journals such as Blood, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.
In The Last Decade
Hyeok Shim
32 papers receiving 617 citations
Peers
Hyeok Shim
Yoon Yang Jung South Korea
Clemens Hufnagl Austria
Zhaohui Wang China
Amy Drobish United States
Magdalena Białas Poland
Joanna Waligórska‐Stachura Poland
Caroline Archer United Kingdom
Lisa Kim United States
Nicholas B. Shannon Singapore
Citations per year, relative to Hyeok Shim Hyeok Shim (= 1×)
peers
Yoon Yang Jung
Countries citing papers authored by Hyeok Shim
Since
Specialization
Citations
This map shows the geographic impact of Hyeok Shim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hyeok Shim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hyeok Shim more than expected).
Fields of papers citing papers by Hyeok Shim
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Hyeok Shim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hyeok Shim. The network helps show where Hyeok Shim may publish in the future.
Co-authorship network of co-authors of Hyeok Shim
This figure shows the co-authorship network connecting the top 25 collaborators of Hyeok Shim. A scholar is included among the top collaborators of Hyeok Shim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hyeok Shim. Hyeok Shim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Lee, Seung‐Hoon, Hyungjin Kim, Gi‐Su Oh, et al.. (2022). Augmentation of NAD+ by Dunnione Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis in Mice. Journal of Inflammation Research. Volume 15. 4623–4636.
2.
Bae, Woo Kyun, Jihyun Kwon, Hyun Woo Lee, et al.. (2018). Feasibility and accessibility of electronic patient-reported outcome measures using a smartphone during routine chemotherapy: a pilot study. Supportive Care in Cancer. 26(11). 3721–3728.
3.
Jeon, Soyeon, Hye Sook Han, Woo Kyun Bae, et al.. (2018). A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy: Results of the Korean South West Oncology Group (KSWOG) Study. Cancer Research and Treatment. 51(1). 90–97.
4.
Lee, So Yeon, Yoon Seok Choi, Ik‐Chan Song, et al.. (2018). Comparison of standard-dose 3-weekly cisplatin and low-dose weekly cisplatin for concurrent chemoradiation of patients with locally advanced head and neck squamous cell cancer. Medicine. 97(21). e10778–e10778.
5.
Choi, Jung Hye, Tae Min Kim, Hyo Jung Kim, et al.. (2017). Multicenter Retrospective Analysis of Clinical Characteristics, Treatment Patterns, and Outcomes in Very Elderly Patients with Diffuse Large B-Cell Lymphoma: The Korean Cancer Study Group LY16-01. Cancer Research and Treatment. 50(2). 590–598.
6.
Lee, Mark Hong, Inho Kim, Yeo-Kyeoung Kim, et al.. (2015). Prediction of survival by applying current prognostic models in diffuse large B-cell lymphoma treated with R-CHOP followed by autologous transplantation. Blood Research. 50(3). 160–160.
7.
Pandit, Arpana, Hyung‐Jin Kim, Gi‐Su Oh, et al.. (2015). Dunnione ameliorates cisplatin-induced small intestinal damage by modulating NAD+ metabolism. Biochemical and Biophysical Research Communications. 467(4). 697–703.
8.
Kim, Hyungjin, Gi‐Su Oh, AiHua Shen, et al.. (2015). Nicotinamide adenine dinucleotide: An essential factor in preserving hearing in cisplatin-induced ototoxicity. Hearing Research. 326. 30–39.
9.
Han, Hye Sook, Ji Chan Park, Suk Young Park, et al.. (2015). A Prospective Multicenter Study Evaluating Secondary Adrenal Suppression After Antiemetic Dexamethasone Therapy in Cancer Patients Receiving Chemotherapy: A Korean South West Oncology Group Study. The Oncologist. 20(12). 1432–1439.
10.
Lee, Mark Hong, Yunsuk Choi, Inho Kim, et al.. (2014). R-CHOP chemoimmunotherapy followed by autologous transplantation for the treatment of diffuse large B-cell lymphoma. Blood Research. 49(2). 107–107.
11.
Kim, Hak-Ryul, Chang‐Duk Jun, Hyeoung‐Joon Kim, et al.. (2014). Aberrant proteomic expression of NSRP70 and its clinical implications and connection to the transcriptional level in adult acute leukemia. Leukemia Research. 38(10). 1252–1259.
12.
Park, Do‐Sim, Ki‐Eun Hwang, Hyeok Shim, et al.. (2011). Elevated survivin is associated with a poor response to chemotherapy and reduced survival in lung cancer with malignant pleural effusions. Clinical & Experimental Metastasis. 29(2). 83–89.
13.
Yhim, Ho‐Young, Jin Seok Kim, Hye Jin Kang, et al.. (2011). Matched‐pair analysis comparing the outcomes of primary breast and nodal diffuse large B‐cell lymphoma in patients treated with rituximab plus chemotherapy. International Journal of Cancer. 131(1). 235–243.
14.
Lee, Sung Sook, Cheolwon Suh, Bong-Seog Kim, et al.. (2010). Bortezomib, doxorubicin, and dexamethasone combination therapy followed by thalidomide and dexamethasone consolidation as a salvage treatment for relapsed or refractory multiple myeloma: analysis of efficacy and safety. Annals of Hematology. 89(9). 905–912.
15.
Hwang, Ki‐Eun, Do‐Sim Park, Keum Ha Choi, et al.. (2010). Apoptotic induction by simvastatin in human lung cancer A549 cells via Akt signaling dependent down-regulation of survivin. Investigational New Drugs. 29(5). 945–952.
16.
Yhim, Ho‐Young, Na‐Ri Lee, Eun‐Kee Song, et al.. (2010). The prognostic significance of tumor human papillomavirus status for patients with anal squamous cell carcinoma treated with combined chemoradiotherapy. International Journal of Cancer. 129(7). 1752–1760.
17.
Yhim, Ho‐Young, Hye Jin Kang, Yoon Hee Choi, et al.. (2010). Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma; Consortium for Improving Survival of Lymphoma (CISL) study. BMC Cancer. 10(1). 321–321.
18.
Kwak, Jae‐Yong, Ho‐Young Yhim, Hye Jin Kang, et al.. (2009). Clinical Features and Treatment Outcomes of Non-Hodgkin's Lymphoma with Breast Involvement; Multi-Institutional Analysis of 98 Patients in Korea.. Blood. 114(22). 5024–5024.
19.
Hong, Joon Pio, Sang-wook Lee, Soo Young Moon, et al.. (2008). Recombinant Human Epidermal Growth Factor Accelerates Recovery of Mouse Small Intestinal Mucosa After Radiation Damage. International Journal of Radiation Oncology*Biology*Physics. 71(4). 1230–1235.
20.
Jang, Kyu Yun, Sung Ho Hwang, Keun Sang Kwon, et al.. (2008). SIRT1 Expression is Associated With Poor Prognosis of Diffuse Large B-Cell Lymphoma. The American Journal of Surgical Pathology. 32(10). 1523–1531.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Yoon Yang Jung Breakdown of academic impact, for papers by Clemens Hufnagl Breakdown of academic impact, for papers by Zhaohui Wang Breakdown of academic impact, for papers by Amy Drobish Breakdown of academic impact, for papers by Magdalena Białas Breakdown of academic impact, for papers by Joanna Waligórska‐Stachura Breakdown of academic impact, for papers by Caroline Archer Breakdown of academic impact, for papers by Lisa Kim Breakdown of academic impact, for papers by Nicholas B. Shannon